Article

Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture

2019-07-01

Abstract excerpt

In the original publication Figures 1 and 3 were swapped. The figure legends were not affected. The correct figure order along with the figure legends are shown below. Generic overview of vaccine manufacturing processes. Operation scheme for the manufacturing of Generalized Modules for Membrane Antigens (GMMA) and RNA vaccines. A) GMMA vaccine production using gram-negative bacteria. GMMA are released constantly d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 792a2d41-d0a5-5330-bfd2-f0db0347630f
DOI: 10.1002/biot.201970055

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureDOI 10.1002/biot.201970055Read

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read

Technologies for the design, discovery, formulation and administration of vaccines.Semantic proximity Read

From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity Read

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentSemantic proximity Read

Recent Advances in mRNA Vaccine DevelopmentSemantic proximity Read

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic DemandSemantic proximity Read

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesSemantic proximity Read

Influenza vaccines: recent advances in production technologiesSemantic proximity Read

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read

Virus-like particles: flexible platforms for vaccine developmentSemantic proximity Read

Production of virus-like particles for vaccinesSemantic proximity Read